CJC-1295 (with DAC)
$70.00
Overview
Research-use GHRH analogue with DAC modification supplied for studies of sustained somatotropic-axis signaling models.
- Concentration
- 5 mg
- Stock
- In stock
Material profile
CJC-1295 with DAC is a modified GHRH analogue used in research models of sustained somatotropic-axis signaling. Pattern lists this material for controlled laboratory research.
- Research Targets
- GHRH receptor signaling, albumin-binding pharmacokinetic models, pituitary somatotroph pathways.
- Key Feature
- DAC modification designed for extended experimental exposure windows.
- Research Focus Areas
- Somatotroph stimulation, GH/IGF-1 pathway signaling, endocrine feedback modeling, pharmacokinetic study designs.
- Common Models
- Pituitary cell assays, rodent endocrine models, receptor-signaling experiments.
- Mechanistic Interests
- GHRH receptor activation, cAMP/PKA signaling, albumin-binding kinetics, downstream IGF-1 pathway markers.
- Use Boundary
- Research use only; not for human or veterinary use; no diagnostic, therapeutic, or consumption use is implied.
Product documentation
Certificate of Analysis
CJC-1295 with DAC
Review the public certificate available for this product before creating an account or checking out.
